More Big Tech earnings rolled in from Amazon and Alphabet.

The bank trimmed its Coinbase revenue and earnings forecasts amid a brutal risk-off environment for crypto and delays around U.S. market structure legislation.

Sysco has outperformed the broader market over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Are Wall Street analysts bullish or bearish on Corteva’s stock post its Q4 earnings release?

GE HealthCare Technologies has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Despite Ameren's underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Campbell's has underperformed the broader market considerably over the past year, and analysts are cautious about the stock’s prospects.

Stellantis reported a massive charge of 22 billion euros ($25.94 billion) as it resets its EV business.

Accenture has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Adobe has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

News of the day for Feb. 6, 2026

Check out the companies making headlines this week:

While Teradyne has surpassed the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Biotech company Biogen (NASDAQ:BIIB) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 7.1% year on year to $2.28 billion. Its non-GAAP profit of $1.99 per share was 22.1% above analysts’ consensus estimates.

Financial advisory firm Perella Weinberg Partners (NASDAQ:PWP) announced better-than-expected revenue in Q4 CY2025, but sales fell by 2.9% year on year to $219.2 million. Its non-GAAP profit of $0.17 per share was 65.9% above analysts’ consensus estimates